Immune Cell Products

Universal CAR-T represents a new generation of cell therapy designed to overcome the limitations of traditional CAR-T approaches, offering cancer patients broader and more accessible treatment options.

CAR-T cell therapy is one of the most advanced immunotherapies in our product pipeline, recognized by both government authorities and international experts.

Within our product pipeline, CAR-NK is a highly promising cell immunotherapy offering new hope for cancer treatment. It is being explored for hematologic malignancies, solid tumors, and autoimmune diseases.

By leveraging our translational research platform and clinical partnerships, our company is developing innovative TIL therapies to address the challenges of solid tumors and provide new treatment options for cancer patients.